G A Siami
Overview
Explore the profile of G A Siami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hutchison A, Barnett M, Krause R, J , Siami G
Clin Nephrol
. 2009 Mar;
71(3):286-95.
PMID: 19281739
Aims: The efficacy and tolerability of the phosphate binder, lanthanum carbonate, have been evaluated in long-term comparative studies and subsequent open-label extensions. Animal studies show that lanthanum has a very...
2.
Malluche H, Siami G, Swanepoel C, Wang G, Mawad H, Confer S, et al.
Clin Nephrol
. 2008 Oct;
70(4):284-95.
PMID: 18826853
Aims: To investigate the evolution of renal osteodystrophy in patients on maintenance dialysis, treated with lanthanum carbonate (LC) vs. standard phosphate-binder therapy (Stx). Materials And Methods: This was a 2-year,...
3.
Siami G, Siami F
Int J Artif Organs
. 2002 Jul;
25(6):499-502.
PMID: 12117288
Over the last 40 years, plasmapheresis technology and its indications for use have been continually evolving. With the growing incidence for autoimmune diseases, unsatisfactory therapeutic options, side effects of drug...
4.
Siami G, Siami F
Ther Apher
. 2001 Nov;
5(4):315-20.
PMID: 11724518
Plasmapheresis is a general term involving extracorporeal plasma separation by centrifugation or primary membrane plasma separator (MPS). Further plasma processing can be accomplished by the use of secondary membrane plasma...
5.
Siami G, Siami F
Ther Apher
. 2001 Nov;
5(4):283-6.
PMID: 11724513
In the last 40 years, therapeutic plasmapheresis techniques have been improving considerably. These include cryofiltration technologies providing novel ways of removing large amounts of cryoproteins from plasma. The concept of...
6.
Siami F, Siami G
ASAIO J
. 2000 Aug;
46(4):383-8.
PMID: 10926132
Over 1,600 plasmapheresis procedures have been performed by using secondary on-line membrane plasma filters in 62 patients over the past 12 years in our institution. The disease categories treated include...
7.
Siami G, Siami F
ASAIO J
. 1999 Jun;
45(3):229-33.
PMID: 10360729
This is the first report on tandem cryofiltration apheresis (CFA) and hemodialysis (HD). A 44 year old white man with Type II mixed cryoglobulinemia, hepatitis C virus (HCV), severe skin...
8.
Siami G, Siami F
Ther Apher
. 1999 May;
2(3):228-35.
PMID: 10227775
There are approximately 2,000 cases of cryoglobulinemia reported each year in the United States. The number of cases has been and is expected to continue growing exponentially since the advent...
9.
Siami G, Siami F, Morrow J, Stone W
Ther Apher
. 1999 May;
1(4):325-9.
PMID: 10225724
Severe anaphylactoid reactions and even death have been reported in hemodialysis patients using certain membrane dialyzers while receiving angiotensin converting enzyme (ACE) inhibitors. We report mild to moderate anaphylactoid reactions...
10.
Siami G, Siami F
Ther Apher
. 1999 Mar;
3(1):8-19.
PMID: 10079800
Therapeutic plasmapheresis has been in widespread use as either a primary or adjunctive therapy in the United States since the 1960s. There are several types of plasmapheresis procedures used to...